Access to anti-retroviral drugs, male in Papua New Guinea
Papua New Guinea: Access to anti-retroviral drugs, male was 50.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, male in Papua New Guinea, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, male in Papua New Guinea stood at 50.0%. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 4.2% on the previous year and up 72.4% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Papua New Guinea peaked at 50.0% in 2024 and was at its lowest, 0.0%, in 2000.
Papua New Guinea ranks 117th of 141 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, male in Papua New Guinea, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 1.0% | — |
| 2006 | 4.0% | +300.0% |
| 2007 | 9.0% | +125.0% |
| 2008 | 12.0% | +33.3% |
| 2009 | 14.0% | +16.7% |
| 2010 | 15.0% | +7.1% |
| 2011 | 17.0% | +13.3% |
| 2012 | 20.0% | +17.6% |
| 2013 | 24.0% | +20.0% |
| 2014 | 29.0% | +20.8% |
| 2015 | 32.0% | +10.3% |
| 2016 | 34.0% | +6.2% |
| 2017 | 36.0% | +5.9% |
| 2018 | 37.0% | +2.8% |
| 2019 | 39.0% | +5.4% |
| 2020 | 41.0% | +5.1% |
| 2021 | 41.0% | +0.0% |
| 2022 | 45.0% | +9.8% |
| 2023 | 48.0% | +6.7% |
| 2024 | 50.0% | +4.2% |
Papua New Guinea compared with similar countries
- Papua New Guinea's 50.0% is below the median for lower middle income countries, which is 71.0%, 70% of the median. (39 countries reporting)
- Papua New Guinea's 50.0% is below the median for East Asia & Pacific, which is 62.0%, 81% of the median. (15 countries reporting)
Biggest year-on-year movements
Years where Access to anti-retroviral drugs, male in Papua New Guinea changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2006 | +300.0% | 1.0% | 4.0% |
| 2007 | +125.0% | 4.0% | 9.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 4.0% | 0.0% | 14.0% | 10 |
| 2010s | 28.3% | 15.0% | 39.0% | 10 |
| 2020s | 45.0% | 41.0% | 50.0% | 5 |
Countries ranked near Papua New Guinea
More gender data for Papua New Guinea
- Child population (UN estimates and projections) 3,665 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 0.4371 % change on previous year (2030)
- Population 8,006 (2030)
- Working-age population (UN estimates and projections) 8,006 (2030)
- Population (UN estimates and projections), annual growth rate 2.07 % change on previous year (2030)
- Age population, age 00, female, interpolated 120,773 (2025)
- Age population, age 00, male, interpolated 129,292 (2025)
- Age population, age 01, female, interpolated 119,621 (2025)
- Age population, age 01, male, interpolated 128,016 (2025)
- Age population, age 02, female, interpolated 119,145 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Papua New Guinea?
- Access to anti-retroviral drugs, male in Papua New Guinea was 50.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Papua New Guinea?
- The highest recorded value was 50.0% in 2024.
- What is the lowest access to anti-retroviral drugs, male recorded in Papua New Guinea?
- The lowest recorded value was 0.0% in 2000.
- How does Papua New Guinea rank for access to anti-retroviral drugs, male?
- Papua New Guinea ranks 117th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in Papua New Guinea?
- Over the last ten years it is up 72.4%. The long-run trend across the full record is volatile.
- Where does this Papua New Guinea data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.